Medtronic PLC Stock Underperforms Tuesday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.Medtronic PLC (MDT) shares fell 1.13% to $82.35 on Tuesday, underperforming the broader market as the S&P 500 and Dow Jones rose. The stock remains 22.55% below its 52-week high of $106.33. Trading volume was notably lower than the 50-day average. Performance varied against competitors: Johnson & Johnson rose, while Danaher and Abbott Laboratories declined.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Medtronic PLC (MDT) shed 1.13% to $82.35 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.89% to 7,509.20 and the Dow Jones Industrial Average rising 0.74% to 52,224.64.
Medtronic PLC closed 22.55% short of its 52-week high of $106.33, which the company reached on November 26th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson (JNJ) rose 0.72% to $250.61, Danaher Corp. (DHR) fell 10.99% to $179.01, and Abbott Laboratories (ABT) fell 1.96% to $99.67.
Trading volume (4.4 M) remained 6.0 million below its 50-day average volume of 10.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 21, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-21-26 1637ET